Gene Therapy and Its Applications in Pharmaceutics
Start with the big picture
This topic introduces how gene therapy transfers or edits genetic material in patient cells and surveys key delivery approaches, including viral vectors such as AAV and lentivirus, liposomes, and CRISPR-based editing. It distinguishes in vivo delivery to tissues from ex vivo approaches such as CAR-T therapy. The lesson also connects these methods with pharmaceutical applications and examples of approved therapies for conditions including spinal muscular atrophy, retinal dystrophy, leukemia, and SCID. Alongside potential benefits, it considers challenges in delivery, cost, regulation, and ethics, as well as the need for rigorous evaluation before approval. Together, these themes provide a foundation for understanding gene therapy as a developing area of pharmaceutical biotechnology.
What you'll learn
- Explain how gene therapy introduces or edits genetic material to address disease.
- Compare in vivo and ex vivo gene therapy approaches.
- Identify delivery methods, including viral vectors, liposomes, and gene editing.
- Describe pharmaceutical applications and examples of approved gene therapies.
- Recognize key scientific, regulatory, and ethical challenges.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
